Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Capital Employed (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Return on Capital Employed data on record, last reported at 0.48% in Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 9.0% year-over-year to 0.48%; the TTM value through Dec 2025 reached 0.48%, down 9.0%, while the annual FY2025 figure was 0.46%, 8.0% up from the prior year.
  • Return on Capital Employed reached 0.48% in Q4 2025 per OCUL's latest filing, up from 0.66% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.23% in Q2 2024 and bottomed at 0.9% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.49%, with a median of 0.48% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: soared 98bps in 2021, then plummeted -41bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.42% in 2021, then tumbled by -52bps to 0.64% in 2022, then rose by 26bps to 0.48% in 2023, then increased by 17bps to 0.4% in 2024, then fell by -22bps to 0.48% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.48% in Q4 2025, 0.66% in Q3 2025, and 0.59% in Q2 2025.